First Manhattan Co. lessened its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 109,571 shares of the pharmacy operator’s stock after selling 3,740 shares during the quarter. First Manhattan Co.’s holdings in Walgreens Boots Alliance were worth $7,987,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of WBA. BlackRock Inc. increased its position in Walgreens Boots Alliance by 1.5% in the second quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock worth $3,189,715,000 after buying an additional 771,307 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec increased its position in Walgreens Boots Alliance by 11.5% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock worth $666,804,000 after buying an additional 1,143,819 shares in the last quarter. Northern Trust Corp increased its position in Walgreens Boots Alliance by 1.9% in the second quarter. Northern Trust Corp now owns 11,102,159 shares of the pharmacy operator’s stock worth $666,296,000 after buying an additional 208,235 shares in the last quarter. Bank of New York Mellon Corp increased its position in Walgreens Boots Alliance by 3.0% in the second quarter. Bank of New York Mellon Corp now owns 10,875,615 shares of the pharmacy operator’s stock worth $652,699,000 after buying an additional 320,484 shares in the last quarter. Finally, LSV Asset Management increased its position in Walgreens Boots Alliance by 17.2% in the second quarter. LSV Asset Management now owns 8,704,233 shares of the pharmacy operator’s stock worth $522,384,000 after buying an additional 1,277,546 shares in the last quarter. Institutional investors own 61.92% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now directly owns 10,943 shares of the company’s stock, valued at $722,128.57. The sale was disclosed in a filing with the SEC, which is available through this link. 14.80% of the stock is currently owned by corporate insiders.

WBA has been the subject of several research analyst reports. Robert W. Baird increased their target price on Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a research report on Friday, October 12th. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Friday, June 22nd. Jefferies Financial Group cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating and cut their target price for the stock from $85.00 to $65.00 in a research report on Friday, June 29th. Barclays increased their target price on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Friday, October 12th. Finally, Citigroup cut Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $69.00 target price for the company. in a research report on Monday, July 9th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $78.22.

Shares of Walgreens Boots Alliance stock opened at $76.58 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $80.68. The company has a market cap of $72.35 billion, a P/E ratio of 15.09, a PEG ratio of 1.11 and a beta of 1.04. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company had revenue of $33.44 billion during the quarter, compared to analyst estimates of $33.64 billion. Research analysts predict that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: Conference Calls and Individual Investors

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.